Lifechem Products
4-Chloro-2-(Methylthio)Pyrimidine | 49844-90-8 | Lazertinib
4-Chloro-2-(Methylthio)Pyrimidine is a highly versatile pyrimidine-based pharmaceutical intermediate that serves as a critical building block in the synthesis of Lazertinib (YH25448), a third-generation EGFR tyrosine kinase inhibitor approved for the treatment of EGFR-mutated non-small cell lung cancer (NSCLC). LifeChem Pharma is a trusted bulk manufacturer and supplier of 4-Chloro-2-(Methylthio)Pyrimidine, offering pharmaceutical-grade material with consistently high purity of ≥98%.
| CAS No : | 49844-90-8 |
|---|---|
| Formula : | C₅H₅ClN₂S |
| Weight : | 160.62 g/mol |
| USE API : | Lazertinib |
Product Specification
- Appearance & Physical State – Colorless to pale yellow liquid
- Assay (HPLC) – ≥ 98%
- Impurity Profile – Controlled as per pharmaceutical standards (ICH Q3A)
- Moisture Content – ≤ 0.5%
- Solubility – Soluble in DMSO, acetonitrile, and common organic solvents
- Storage Condition – Store in cool, dry, well-ventilated area away from moisture and heat
- Packaging – 1 L / 5 L / 25 L / 200 L HDPE jerrycan or drum
Safety Information As Per GHS
- Irritating to skin, eyes, and respiratory tract upon contact
- Avoid inhalation of dust or vapors during handling
- Use appropriate personal protective equipment including gloves, goggles, and mask
- Keep container tightly sealed away from moisture and heat sources
- Refer to the Safety Data Sheet (SDS) for complete hazard classification and first-aid measures
4-Chloro-2-(Methylthio)Pyrimidine (CAS No. 1996-07-2) is a pyrimidine derivative with the molecular formula C₅H₅ClN₂S and a molecular weight of 160.62 g/mol. The structure features a six-membered pyrimidine ring with a reactive chloro (–Cl) group at the 4-position and a methylthio (–SCH₃) group at the 2-position. This dual functionality makes 4-Chloro-2-(Methylthio)Pyrimidine an exceptionally useful electrophilic building block, enabling selective nucleophilic aromatic substitution reactions at both positions under controlled reaction conditions







Recent Comments